Drug Development in Pemphigoid Diseases by Katja Bieber, Ralf J. Ludwig

Connect to this object online.

Increased Risk of Pemphigus among Patients with Psoriasis: A Large-scale Cohort Study by Khalaf Kridin, Ralf J. Ludwig, Giovanni Damiani, Arnon D. Cohen

Connect to this object online.

Comparison of safety profile in patients with atopic dermatitis treated with dupilumab or conventional systemic treatment: real world data from the US network by Henner Zirpel, Ralf J. Ludwig, Henning Olbrich, Khalaf Kridin, Sascha Ständer, Diamant Thaçi

Connect to this object online.

Survival of Adjuvant Drugs for Treatment of Pemphigus: A Population-based Cohort Study by Khalaf Kridin, Christoph M. Hammers, Ralf J. Ludwig, Dana Tzur Bitan, Arnon D. Cohen

Connect to this object online.

Sustained CD19+CD27+ Memory B Cell Depletion after Rituximab Treatment in Patients with Pemphigus Vulgaris by Katharina Boch, Ewan A. Langan, Enno Schmidt, Detlef Zillikens, Ralf J. Ludwig, Katja Bieber, Christoph M. Hammers

Connect to this object online.

Faster IgG4 Depletion Kinetics Observed for Anti-Desmoglein 3 Autoantibodies Following Rituximab Treatment in Patients with Pemphigus Vulgaris by Katharina Boch, Ewan A. Langan, Nina van Beek, Khalaf Kridin, Enno Schmidt, Detlef Zillikens, Ralf J. Ludwig, Christoph M. Hammers, Katja Bieber

Connect to this object online.

Reduced Skin Blistering in Experimental Epidermolysis Bullosa Acquisita After Anti-TNF Treatment by Misa Hirose, Anika Kasprick, Foteini Beltsiou, Katharina Schulze Dieckhoff, Franziska Sophie Schulze, Unni K J S R L Samavedam, Jennifer E Hundt, Hendri H Pas, Marcel F Jonkman, Enno Schmidt, Kathrin Kalies, Detlef Zillikens, Ralf J Ludwig, Katja Bieber

Connect to this object online.